CFO Wayne Deveydt Buys Shares of UnitedHealth Group
Wayne Deveydt, the CFO of UnitedHealth Group, purchased 112 shares on June 23, 2026.
Key Points
- Wayne Deveydt, CFO of UnitedHealth Group, purchased 112 shares on June 23, 2026.
- UnitedHealth's stock traded near $415.53 on Friday, with a market cap of $369.3 billion and a P/E ratio of 30.6.
- Analysts maintain a 'buy' rating with a target mean price of $409.77 and a high target of $492.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Wayne Deveydt, the Chief Financial Officer of UnitedHealth Group Incorporated, bought 112 shares of the company on June 23, 2026. This transaction was not part of a pre-planned trading program. Shares of UnitedHealth Group, listed on the NYSE under the ticker UNH, traded near $415.53 on Friday.
UnitedHealth Group Incorporated Stock Up 5.7%
Shares of NYSE:UNH traded close to $415.53 on Friday. UnitedHealth Group has a market capitalization of about $369.3 billion, with a P/E ratio of 30.6 and a forward P/E of 19.4. The stock has a 52-week low of $234.60 and a 52-week high of $415.98. Its 50-day moving average is $372.67, and the 200-day moving average is $333.55. The company has a beta of 0.65, indicating relatively low volatility compared to the market.
$UNH stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
In its most recent earnings report, UnitedHealth Group reported revenue of approximately $449.7 billion, reflecting a growth rate of 2%. The company's net margin stood at 2.68%, and it achieved a return on equity of 12.18%. The next earnings report is anticipated on July 16, 2026.
Dividend
UnitedHealth Group pays an annual dividend of $9.28 per share, yielding 2.31%. The dividend payout ratio is 66.57%, indicating the proportion of earnings paid out as dividends to shareholders.
Insider Buying and Selling at UnitedHealth Group Incorporated
On June 23, 2026, several insiders at UnitedHealth Group made stock purchases. Besides Wayne Deveydt, Frederick William McNabb III bought 50 shares, Paul Garcia acquired 13 shares, Charles Baker also bought 13 shares, and Christopher Zaetta, EVP & Chief Legal Officer, purchased 61 shares. Timothy Patrick Flynn and CEO Stephen Hemsley each acquired 61 and 46 shares, respectively. None of these transactions were planned trades.
Analysts Set New Price Targets
On June 24, 2026, B of A Securities maintained its 'buy' rating on UnitedHealth Group with a price target of $475. Earlier in June, other firms such as Leerink Partners and Mizuho also maintained 'buy' ratings with targets of $462 and $460, respectively. The consensus among 26 analysts is a 'buy' recommendation, with a target mean price of $409.77.
About UnitedHealth Group
UnitedHealth Group Incorporated is a leading healthcare company headquartered in Eden Prairie, Minnesota. The company operates through several segments including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. It provides a wide range of healthcare products and services, including health benefit plans and pharmacy care services, to various customers including employers, government agencies, and individuals. UnitedHealth Group was founded in 1974 and employs around 390,000 people.
Bottom Line
Wayne Deveydt's recent share purchase is a notable insider transaction at UnitedHealth Group. Investors often track insider activity for potential insights into a company's future prospects. However, it's important to remember that insider transactions like these are backward-looking and may not necessarily predict future stock performance. UnitedHealth Group remains a major player in the healthcare sector, with analysts broadly maintaining a positive outlook on its stock.
Get UnitedHealth Group Incorporated alerts
New 13F filings, insider trades, and analyst moves on $UNH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.